O
OpenEvidence
AI-driven clinical decision support enhancing healthcare outcomes at the point of care
Open roles
| Role | Team | Location | Posted |
|---|---|---|---|
| Member of Technical Staff, Health SystemsEngineering | Engineering | San Francisco | 1mo ago |
| Member of Technical Staff, Beneficial Deployments | Miami | 2mo ago | |
| Health System PartnershipsSales | Sales | Remote | 2mo ago |
| Software Engineer, Backend and InfrastructureEngineering | Engineering | Miami | 9mo ago |
| Security EngineerEngineering | Engineering | Miami | 9mo ago |
| Software Engineer, Site ReliabilityEngineering | Engineering | Miami | 9mo ago |
| Research ScientistData & AI | Data & AI | San Francisco | 9mo ago |
| Member of Technical StaffEngineering | Engineering | San Francisco | 10mo ago |
OpenEvidence in the Miami ecosystem
The OpenEvidence office with the hot startups, most funded companies and investors around it. Hover or tap a pin.
Dealroom maps whole ecosystems like this one for cities, regions and governments. See the ecosystem platform →
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Series B and later12 investors entered at this stage
Ownership
Estimated cap table from Dealroom's shareholder data — share of equity by holder. Stakes as last recorded by Dealroom (Jan/2026). Percentages are indicative.
Some investors are hidden on this public profile. See the full cap table on Dealroom →
Source: Dealroom Talent Intelligence.
Global footprint
Patents
4 active patent families included in this estimate.
A patent family groups patent filings for the same invention. Source: Dealroom · PatSnap.
Investments and acquisitions
Disclosed deals where OpenEvidence was the backer or acquirer, 2025–2025. Toggle between venture rounds, M&A, or both. The map below is grouped by the target company's sector — the colored pill on each chip is the round type.
1 deals across OpenEvidence's capital deployment.
Where the deals concentrate by sector, stage, and decade.
OpenEvidence's portfolio, mapped.
See OpenEvidence on the full Dealroom platform
Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.
Vera Health raises $28.5M Series A as clinical AI tool hits 800,000 users
OpenEvidence raises $250M at $15B, pivots into drug development
OpenEvidence hiring for founder-led special projects









